Gray Market
September 2017 : Generic Drugs - Vol. 14 No. 9 - Page #8

The trend of diminishing reliance on the gray market to procure pharmaceuticals saw a disturbing reversal this year, despite the fact that most facilities with a policy in place forbid this potentially dangerous practice. It appears to be time for the 57% of facilities without an official policy in place to commit to crafting one.

To read the full article, please log in or register.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register: